324 related articles for article (PubMed ID: 20833545)
1. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
[TBL] [Abstract][Full Text] [Related]
2. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
Shimamura H; Gouda H; Nagai K; Hirose T; Ichioka M; Furuya Y; Kobayashi Y; Hirono S; Sunazuka T; Omura S
Angew Chem Int Ed Engl; 2009; 48(5):914-7. PubMed ID: 19115340
[No Abstract] [Full Text] [Related]
3. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of Antibacterial Activity of Bottromycins.
Yamada T; Yagita M; Kobayashi Y; Sennari G; Shimamura H; Matsui H; Horimatsu Y; Hanaki H; Hirose T; O Mura S; Sunazuka T
J Org Chem; 2018 Jul; 83(13):7135-7149. PubMed ID: 29560726
[TBL] [Abstract][Full Text] [Related]
6. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.
Bürli RW; McMinn D; Kaizerman JA; Hu W; Ge Y; Pack Q; Jiang V; Gross M; Garcia M; Tanaka R; Moser HE
Bioorg Med Chem Lett; 2004 Mar; 14(5):1253-7. PubMed ID: 14980676
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Krause KM; Barriere SL; Kitt MM; Benton BM
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):181-5. PubMed ID: 20846593
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Aug; 19(16):4626-9. PubMed ID: 19589676
[TBL] [Abstract][Full Text] [Related]
10. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
Vairappan CS; Kawamoto T; Miwa H; Suzuki M
Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Inagaki H; Miyauchi S; Miyauchi RN; Kawato HC; Ohki H; Matsuhashi N; Kawakami K; Takahashi H; Takemura M
J Med Chem; 2003 Mar; 46(6):1005-15. PubMed ID: 12620077
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Hossion AM; Otsuka N; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Zamami Y; Sasaki K
Bioorg Med Chem Lett; 2010 Sep; 20(17):5349-52. PubMed ID: 20655215
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of liposome encapsulated cyclo(L-tyrosyl-L-prolyl).
Kilian G; Tshanga SS; Oidu B; Milne PJ
Pharmazie; 2011 Jun; 66(6):421-3. PubMed ID: 21699080
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Mar; 19(5):1292-5. PubMed ID: 19208475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
